Supplementary Table S7 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
Abstract
Frequency of AR H875Y mutations and HLA allotypes in the Herberts and colleagues, 2022 Cohort
Fields of Study & Subjects
Prostate Cancer Treatment and Research
Cancer Immunotherapy and Biomarkers
Immunotherapy and Immune Responses
Publication details
- Publication date
- 6 February 2026